Stocktoria
HUTCHMED (China) Ltd HCM
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2006-05-19
Chart by TradingView
5/9
Piotroski F — financial health
6.45
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $548.5M | $630.2M | $838.0M | $426.4M | $356.1M |
| Operating income | -$39.2M | -$43.7M | $18.4M | -$407.7M | -$328.3M |
| Net income | $456.9M | $37.7M | $100.8M | -$360.8M | -$194.6M |
| Operating cash flow | -$64.7M | $497,000 | $219.3M | -$268.6M | -$204.2M |
| Free cash flow | -$78.8M | -$17.4M | $186.6M | -$305.3M | -$220.6M |
| Total assets | $1.8B | $1.3B | $1.3B | $1.0B | $1.4B |
| Total liabilities | $501.8M | $502.3M | $536.4M | $392.6M | $333.1M |
| Shareholders' equity | $1.3B | $771.9M | $743.4M | $636.9M | $1.0B |
| Ratios | |||||
| Operating margin | -7.1% | -6.9% | 2.2% | -95.6% | -92.2% |
| Net margin | 83.3% | 6.0% | 12.0% | -84.6% | -54.7% |
| FCF margin | -14.4% | -2.8% | 22.3% | -71.6% | -62.0% |
| Return on assets | 26.1% | 3.0% | 7.9% | -35.1% | -14.2% |
| Return on equity | 36.5% | 4.9% | 13.6% | -56.7% | -18.7% |
| Debt / equity | 0.07× | 0.11× | 0.06× | 0.03× | — |
| Current ratio | 4.96 | 2.83 | 2.72 | 2.37 | 3.89 |
| Revenue growth | -13.0% | -24.8% | 96.5% | 19.7% | 56.2% |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 132,062 | $2.0M |
Why these scores methodology →
Piotroski F-score: 5/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 6.45 (safe)
- Working capital / assets 0.714
- Retained earnings / assets -0.216
- EBIT / assets -0.022
- Equity / liabilities 2.493
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001648257 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.